<DOC>
	<DOCNO>NCT00650403</DOCNO>
	<brief_summary>The objective study investigate bioequivalence Mylan 's paroxetine hydrochloride 40 mg tablet GSK 's Paxil® 40 mg tablet follow single , oral 40 mg ( 1 x 40 mg ) dose administer fed condition healthy adult volunteer .</brief_summary>
	<brief_title>Food Study Paroxetine Hydrochloride Tablets 40 mg Paxil® Tablets 40 mg</brief_title>
	<detailed_description />
	<mesh_term>Paroxetine</mesh_term>
	<criteria>1 . Subjects informed nature study agree read , review , sign inform consent document prior Period I dose . 2 . Subjects complete screen process within 21 day prior Period I dose . 3 . Subjects healthy adult men woman least 18 year age time dose . 4 . Subjects weigh least 60 kg ( 132 lb ) men 48 kg ( 106 lb ) woman . All subject must Body Mass Index ( BMI ) less equal 30 great equal 19 . 5 . Subjects healthy document medical history , physical examination ( include limit evaluation cardiovascular , gastrointestinal , respiratory , central nervous system ) , vital sign assessment , 12lead electrocardiogram ( ECG ) , clinical laboratory assessment , general observation . Any abnormalities/deviations normal range consider clinically relevant study physician investigator evaluate individual case , document study file , agree upon investigator clinic personnel prior enrol volunteer study continue enrollment . 6 . Subjects negative urine drug screen . 7 . Female subject negative pregnancy screen . 8 . Female subject physically incapable pregnancy surgically sterile ( bilateral oophorectomy absence bleed six month , without hysterectomy , total hysterectomy absence bleed least three month ) postmenopausal absence menses least 12 month . 9 . During course study , study screen study exit include washout period , men use spermicide contain barrier method contraception . 1 . Institutionalized subject use . 2 . Social Habits : . Use tobaccocontaining product within one ( 1 ) year prior dose . b. Ingestion alcoholic , caffeine xanthinecontaining food beverage within 48 hour prior initial dose study medication . c. Ingestion vitamin herbal product within 7 day prior initial dose study medication . d. Any recent , significant change dietary exercise habit . e. A positive test drug include urine drug screen . f. History drug and/or alcohol abuse . 3 . Medications : . Use prescription overthecounter ( OTC ) medication within 14 day prior initial dose study medication . b . Use hormonal contraceptive hormone replacement therapy within 3 month prior study medication dosing . c. Use medication within 28 day prior initial dose study medication unless Pharmacokinetics/Drug Metabolism Department Mylan consult decision make allow subject enroll base medication pharmacology pharmacokinetics . d. Use monoamine oxidase inhibitor ( MAOIs ) , pimozide , thioridazine within 30 day prior initial dose study medication . 4 . Diseases : . History significant cardiovascular , hepatic , renal , pulmonary , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic disease . b . Acute illness time either prestudy medical evaluation dosing . c. A positive HIV , hepatitis B , hepatitis C test . 5 . Abnormal clinically significant laboratory test result : a. Clinically significant deviation Guide Clinically Relevant Abnormalities . b. Abnormal clinically relevant ECG tracing . 6 . Donation loss significant volume blood plasma ( &gt; 450 mL ) within 28 day prior initial dose study medication . 7 . Subjects receive investigational drug within 30 day prior initial dose study medication . 8 . Allergy hypersensitivity paroxetine relate product . 9 . History difficulty swallow , gastrointestinal disease could affect drug absorption . 10 . Consumption grapefruit grapefruit containing product within seven ( 7 ) day drug administration . 11 . History depression , mania , seizure , akathisia , narrow angle glaucoma , and/or suicidal ideation behavior ( suicidality ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>